89852-17-5,
methyl 2-(3-oxopiperazin-2-yl)acetate,
methyl (3-oxo-2-piperazinyl)acetate,
(3-Oxo-piperazin-2-yl)-acetic acid methyl ester,
methyl (3-oxopiperazin-2-yl)acetate,
methyl 2-(3-oxo-2-piperazinyl)acetate,
2-Piperazineaceticacid, 3-oxo-, methyl ester,
ACMC-20eevy,
BAS 09896277,
AC1MH9F2,
MLS000058006,
AC1Q441Q,
ARONIS006501,
SCHEMBL3545687,
CHEMBL1578724,
CTK5G3601,
KS-00003YSK,
DTXSID10388189,
IPEHBEGTVNYMPV-UHFFFAOYSA-N,
HMS2372F09,
ALBB-016885,
2418AF,
BBL012891,
MFCD03011617,
SBB010536,
STK124620,
AKOS000122542,
AKOS016039802,
MCULE-7143283004,
SMR000063193,
ST096674,
DB-078528,
TR-047881,
BB 0219242,
EU-0014250,
FT-0694553,
EN300-04013,
2-Piperazineacetic acid, 3-oxo-, methyl ester,
W-9962,
(3-Oxo-piperazin-2-yl)acetic acid methyl ester,
Methyl (3-oxopiperazin-2-yl)acetate, AldrichCPR,
Z56971008,
F1260-1558,
A3311/0140761,
C7H12N2O3,
CID2998378,
methyl2-[ -3-oxo-2,4,5,6-tetrahydropyrazin-2-yl]acetate,
33422-35-4,